Key Highlights
- POET shares skyrocketed more than 24% during premarket hours Thursday following the Lumilens partnership announcement.
- The agreement includes an opening purchase order valued at $50M for POET’s Electrical-Optical Interposer (EOI) engines.
- Total purchases under the agreement framework could climb to $500M across a five-year period.
- As part of the arrangement, POET issued Lumilens a warrant for up to 22.92 million shares at $8.25 each, valid for nine years.
- Initial engineering samples are slated for late 2026, with full-scale production aimed at hyperscaler customers in 2027.
POET Technologies (POET) experienced a significant surge of over 24% in premarket trading Thursday morning following the announcement of a comprehensive supply and development partnership with Lumilens Inc.
At the heart of this agreement lies POET’s Electrical-Optical Interposer (EOI) technology — an innovative wafer-level manufacturing platform designed for optical engines powering AI data center infrastructure.
Lumilens initiated the partnership with a substantial $50 million initial purchase order for EOI-powered engines. However, this opening commitment represents merely the starting point — the comprehensive agreement establishes a structure for aggregate purchases potentially exceeding $500 million throughout a five-year timeframe.
This collaboration extends beyond a standard commercial transaction. It represents a joint development initiative where both organizations will co-engineer the EOI platform, merging POET’s wafer-level photonic integration expertise with Lumilens’ optical chipset technology and production infrastructure.
The objective is to eliminate conventional active-alignment manufacturing processes in favor of wafer-scale production — effectively applying semiconductor manufacturing precision and efficiency to optical engine fabrication.
Understanding the Warrant Structure
In conjunction with the supply partnership, POET issued Lumilens a warrant providing the right to acquire up to 22,921,408 common shares at an exercise price of $8.25 per share.
Approximately 2.29 million shares under this warrant can be exercised immediately. The remaining shares vest incrementally based on Lumilens’ cumulative spending on subsequent purchase orders — scaling up to the $500 million maximum threshold.
The warrant carries a nine-year term, providing Lumilens considerable flexibility to exercise as the commercial relationship expands and matures.
Ankur Singla, CEO of Lumilens, identified GPU interconnects as the primary limitation constraining AI infrastructure scaling, emphasizing that this partnership aims to resolve that bottleneck through advanced optical solutions.
Dr. Suresh Venkatesan, POET’s Chairman and CEO, characterized the agreement as validation of POET’s manufacturing methodology — delivering “semiconductor-style discipline” to optical engine production at commercial scale.
Development Roadmap and Timeline
The collaborative development plan encompasses multiple product generations, beginning with 800G and 1.6T pluggable transceiver solutions before progressing to Near-Package Optics and Co-Packaged Optics configurations.
Engineering validation samples from this joint development effort are anticipated in the latter part of 2026. Volume production deployment, focused on hyperscaler data center customers, is targeted for 2027.
This schedule depends on successful completion of module development and qualification processes, plus adequate scaling of manufacturing infrastructure — typical qualifications accompanying any emerging hardware development initiative.
POET was trading approximately 16% higher during Thursday morning sessions, moderating somewhat from the premarket peak while maintaining substantial gains for the day.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
